Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Ferrari, Cristina ^a   Niccoli Asabella, Artor ^a   Villano, Carlo ^b   Giacobbi, Beatrice ^c   Coccetti, Daniela ^c   Panichelli, Paola ^c   Rubini, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b SPIRITO SANTO HOSPITAL   (Italy)

^c Advanced Center Oncology Macerata (ACOM) SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER DICHLORIDE CU 64; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; COPPER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; DRUG DISTRIBUTION; DRUG EFFICACY; GLIOBLASTOMA; IMAGE ANALYSIS; KIDNEY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE THERAPY; SHOULDER; TREATMENT RESPONSE; TUMOR XENOGRAFT; ANIMAL; BRAIN; DIAGNOSTIC IMAGING; DRUG SCREENING; HUMAN; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION RESPONSE; THERANOSTIC NANOMEDICINE; TISSUE DISTRIBUTION; TUMOR CELL LINE; X-RAY COMPUTED TOMOGRAPHY;

ANIMALS; BRAIN; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; COPPER RADIOISOTOPES; GLIOBLASTOMA; HUMANS; MICE; THERANOSTIC NANOMEDICINE; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84948807598     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/129764     Document Type: Article

References (15)

1. D. A. Reardon, J. N. Rich, H. S. Friedman, and D. D. Bigner, "Recent advances in the treatment of malignant astrocytoma," Journal of Clinical Oncology, vol. 24, no. 8, pp. 1253-1265, 2006.
2. A. Niccoli Asabella, G. L. Cascini, C. Altini, D. Paparella, A. Notaristefano, and G. Rubini, "The copper radioisotopes: a systematic review with special interest to 64Cu," BioMed Research International, vol. 2014, Article ID 786463, 9 pages, 2014.
3. J. T. Jørgensen, M. Persson, J. Madsen, and A. Kjær, "High tumor uptake of 64Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers," Nuclear Medicine and Biology, vol. 40, no. 3, pp. 345-350, 2013.
4. C. Qin, H. Liu, K. Chen et al., "Theranostics of malignant melanoma with 64CuCl2," Journal of Nuclear Medicine, vol. 55, no. 5, pp. 812-817, 2014.
5. E. Capasso, S. Durzu, S. Piras et al., "Role of 64CuCl2 PET/CT in staging of prostate cancer," Annals of Nuclear Medicine, vol. 29, no. 6, pp. 482-488, 2015.
6. F. Peng, X. Lu, J. Janisse, O. Muzik, and A. F. Shields, "PEt of human prostate cancer xenografts in mice with increased uptake of 64CuCl2," Journal of Nuclear Medicine, vol. 47, no. 10, pp. 1649-1652, 2006.
7. L. Evangelista, M. Luigi, and G. L. Cascini, "New issues for copper-64: from precursor to innovative PET tracers in clinical oncology," Current Radiopharmaceuticals, vol. 6, no. 3, pp. 117-123, 2013.
8. M. A. Cater, H. B. Pearson, K. Wolyniec et al., "Increasing intracellular bioavailable copper selectively targets prostate cancer cells," ACS Chemical Biology, vol. 8, no. 7, pp. 1621-1631, 2013.
9. C. L. Ferreira, D. T. T. Yapp, S. Crisp et al., "Comparison of bifunctional chelates for 64Cu antibody imaging," European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 11, pp. 2117-2126, 2010.
10. C. F. Ramogida and C. Orvig, "Tumour targeting with radiometals for diagnosis and therapy," Chemical Communications, vol. 49, no. 42, pp. 4720-4739, 2013.
11. K. S.Woodin, K. J. Heroux, C. A. Boswell et al., "Kinetic inertness and electrochemical behavior of copper(II) tetraazamacrocyclic complexes: possible implications for in vivo stability," European Journal of Inorganic Chemistry, vol. 2005, no. 23, pp. 4829-4833, 2005.
12. A. A. S. Tavares and J. M. R. S. Tavares, "99mTc Auger electrons for targeted tumour therapy: a review," International Journal of Radiation Biology, vol. 86, no. 4, pp. 261-270, 2010.
13. W. Beaino, Y. Guo, A. J. Chang, and C. J. Anderson, "Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy," Journal of Biological Inorganic Chemistry, vol. 19, no. 3, pp. 427-438, 2014.
14. S. Ishida, P. Andreux, C. Poitry-Yamate, J.Auwerx, andD.Hanahan, "Bioavailable copper modulates oxidative phosphorylation and growth of tumors," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 48, pp. 19507-19512, 2013.
15. C. S. Cutler, H.M. Hennkens, N. Sisay, S. Huclier-Markai, and S. S. Jurisson, "Radiometals for combined imaging and therapy," Chemical Reviews, vol. 113, no. 2, pp. 858-883, 2013.